Supply of Diverse Pharmaceuticals for Indian Air Force

Work Description - NA

This tender description outlines an opportunity for the supply of essential pharmaceuticals to the Indian Air Force, under the purview of the Department of Military Affairs and the Ministry of Defence. The bid, identified by GEM/2026/B/7879264, is open from August 29, 2026, at 2:18 PM and closes on September 8, 2026, at 3:00 PM. The procurement encompasses a diverse range of medications, including but not limited to Ramipril 10 mg, Metoprolol 12.5 mg, Frusemide 40 mg, Spironolactone 25 mg, Sulphasalazine 500 mg, Gliclazide MR 30 mg, Nitrofurantoin 100 mg, Methotrexate 5 mg, Amiodarone HCl 100 mg, Sodium Valproate CR 300 mg, Rosuvastatin 20 mg, Hydrochlorothiazide 12.5 mg, Lacosamide 50 mg, Telmisartan 20 mg, Mirabegron 25 mg, Mirabegron 50 mg, as well as Formoterol 6 MCG/Budesonide 400 MCG Rotacaps and Formoterol 6 MCG/Budesonide 200 MCG Rotacaps, and Dienogest 2 mg tablets. The total quantity required for these items is 139,140 units. Applications should be submitted in accordance with the specified bid details, targeting the procurement needs of the Indian Air Force located in Kanpur City.